The Best of MEDEZE – Excellence in Stem Cell Banking
Today, it must be acknowledged that medical advancements are advancing rapidly. New technologies and knowledge in diagnosis and treatment continue to emerge. One of the disciplines that has gained widespread recognition and increasing adoption is stem cell therapy, or regenerative medicine, which focuses on the use of stem cells (progenitor cells) that can self-renew and differentiate into various tissues. Stem cells are used in the treatment of various diseases, particularly degenerative diseases.
คลิกดูรายละเอียดเพิ่มเติมได้ที่นี่ ข้อมูลเพิ่มเติมเรื่องการรักษาด้วยสเต็มเซลล์
However, the application of stem cells in medical treatment requires an appropriate source. Generally, stem cells may be obtained from donors (an option that carries risks related to contamination and tissue incompatibility) or from an individual’s own stem cells. Autologous stem cells can be collected while a person is still healthy, or even preserved from placental tissue at birth, and stored in a stem cell bank for future clinical use.
In Thailand, only a limited number of providers offer stem cell banking services. MEDEZE is recognized as one of the true pioneers and leaders in the Thai stem cell industry. MEDEZE was founded through the collaboration of leading physicians and stem cell scientists in Thailand. The company was established in 2010 under the name Bangkok Stem Cell Co., Ltd., led by Dr. Veerapol Khemarangsan, before later rebranding as MEDEZE. Over the past 11 years, MEDEZE has consistently delivered services that meet the highest standards for the Thai population, with 5 outstanding features that are the best of MEDEZE.
The Five Outstanding Features of MEDEZE as a Leading Stem Cell Bank
The Best of Stem Cell: Excellence in comprehensive stem cell care across all age groups. MEDEZE is the only stem cell bank in Thailand capable of storing stem cells from both umbilical cord tissue and adipose tissue, enabling services that cover a wide range of ages and expanding opportunities for diverse stem cell preservation options.
The Best of Technology: Excellence in advanced technology through the AXP AutoXpress Platform, the only fully automated stem cell separation system in Thailand. This technology achieves a stem cell recovery rate of up to 98.7%, significantly reducing contamination risks and human error compared to manual separation methods.[1,2] All processes are conducted within laboratories that meet the highest cleanliness and safety standards.
The Best of Professional Team: Excellence in professional expertise led by Dr. Veerapol Khemarangsan, together with Assoc. Prof. Dr. Rangsan Palapai, Director of the Center for Embryo and Stem Cell Technology Research at Suranaree University of Technology and President of the Thailand Stem Cell Society, and Dr. Jamras Sakulpaisal, Founder of the Assisted Reproductive Technology Center at Maharaj Hospital, Nakhon Ratchasima. The three founders of MEDEZE are among Thailand’s foremost stem cell specialists.
The Best of Quality Confirmation: Excellence in standards and recognition. MEDEZE is accredited by the American Association of Blood Banks (AABB) for stem cell processing, long-term storage, and transportation for clinical use—one of the most stringent accreditation bodies for stem cell banks worldwide. In addition, MEDEZE has been honored by Frost & Sullivan, a global brand evaluation firm, as Thailand Stem Cell Banking Company of the Year for four consecutive years.
The Best of Value: Excellence in value-driven storage plans. MEDEZE offers lifetime stem cell storage, unlike other providers that typically limit storage to 20 years (extended to 60 years under stock exchange accounting regulations). Through strategic financial planning, MEDEZE can provide a full refund of storage fees upon contract completion, along with stem cell quality insurance coverage up to 10 times the service fee and bone marrow transplantation support of up to 2,000,000 THB.
With the founders’ commitment to making high-quality stem cells accessible to Thai people, MEDEZE strives to deliver “a longer life”, empowering individuals to live fully and enjoy meaningful moments with their loved ones.
References
1) Rubinstein P. Cord blood banking for clinical transplantation. Bone marrow transplantation. 2009 Nov;44(10):635-42.
2) Basford C, Forraz N, Habibollah S, Hanger K, McGuckin CP. Umbilical cord blood processing using Prepacyte‐CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation. Cell proliferation. 2009 Dec;42(6):751-61.